Global Compression Therapy Market Size, Share, Growth Analysis, By Product(Compression Pumps, Compression Garments), By Technique(Static Compression Therapy, Dynamic Compression Therapy) - Industry Forecast 2024-2031

Compression Therapy Market size was valued at USD 3.89 billion in 2019 and is poised to grow from USD 4.14 billion in 2023 to USD 6.68 billion by 2031, growing at a CAGR of 6.2% in the forecast period (2024-2031).

The main competitors in the compression therapy market are concentrating their efforts on expanding their worldwide and regional customer bases through acquisitions, mergers, and expansions. Companies in the compression therapy market use acquisition, regulatory clearances, and the introduction of new products as their main strategies. Key businesses are focusing their efforts on the creation of advanced and affordable products as well as on distribution deals to broaden their market reach, notably in Asia Pacific. In our Compression Therapy market reports, some of the leading Compression Therapy players are as follows: medi GmbH & Co. KG (Germany), Medtronic plc (Ireland), SIGVARIS GROUP. (US), Juzo (Germany), PAUL HARTMANN AG (Germany), 3M (US), Spectrum Healthcare. (India), BIOCOMPRESSION SYSTEMS (US), Gottfried Medical, Inc. (US), BSN medical (Germany), Arjo. (Sweden), DJO, LLC (US), Tactile Medical (US), SANYLEG SRL a socio unico (Italy), Cardinal Health. (US), Devon Medical Products (US), THUASNE SAS (US), ACI Medical, LLC (US), Ofa Bamberg GmbH (Germany), Mego Afek A.C. ltd. (Israel), Medline Industries, Inc. (US) 'Medtronic plc', '3M Company', 'Smith & Nephew plc', 'BSN Medical GmbH', 'Bio Compression Systems, Inc.', 'Tactile Medical', 'DJO Global, Inc.', 'Medi GmbH & Co. KG', 'SIGVARIS Group', 'ArjoHuntleigh, Inc.', 'Bauerfeind AG', 'Össur hf', 'Paul Hartmann AG', 'Bioventus LLC', 'Zimmer Biomet Holdings, Inc.', 'Kinesio Holding Corporation', 'Compression Therapy Concepts, Inc.', 'Human Care Group AB', 'Mego Afek Acrylic & Plastics Ltd.', 'Julius Zorn GmbH'

There have been rapid technological advancements in the field of wound care, as well as an increase in the number of clinics offering prevention and rehabilitation services.

For patients with cystic fibrosis (CF), the most recent high frequency chest compression (HFCC) technology is used to remove mucus discharges from airways and enhance lung function. The system comprises of a variable air pulse delivery system and a non-stretch inflatable vest worn by the patient to cover the chest bandages. The bandages are applied at full stretch and feature printed ovals or rectangles for improved bandage extension.

North America is anticipated to hold the greatest market share for compression therapy in 2021. This is mostly due to the increase in orthopaedic and spinal operations, the rise in lymphedema, varicose veins, and DVT cases, the frequency of sports injuries, and the existence of several compression therapy product producers in the area.